IP Library Patent Application 12586038
Patent Application
App. No. 12/586,038

Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/586,038
Abstract

A dosage comprising an antibiotic, an estrogen, and a progestagen is provided. The dosage can be oral, or administered in other methods, such as intravaginally with a tampon. The dosage can be used for menstrual suppression, contraception, and/or hormone replacement therapy. A method of treating a patient with the dosage comprises administering the dosage to the patient over a course of treatment, in amounts or frequencies that can remain constant, or be varied.

Claims (30)

1 . A dosage for use for menstrual suppression, contraception, and/or hormone replacement therapy, comprising:

an antibiotic; and

at least one of an estrogen and a progestagen.

2 . A dosage, comprising:

an antibiotic;

an estrogen;

and a progestagen.

3 . The dosage of claim 2 , wherein said antibiotic is a tetracycline.

4 . The dosage of claim 3 , wherein said tetracycline is selected from the group consisting of doxycycline, doxycycline hydrochloride, demeclocycline, meclocycline sulfosalicyate, minocylcine hydrochloride, oxytetracycline, tetracycline hydrochloride, and any combinations thereof.

5 . The dosage of claim 2 , wherein said antibiotic is selected from the group consisting of penicillin, oxacillin, erythromycin, ciprofloxacin, methicillin, nafcillin, clindamycin, vancomysin, ampicillin, and any combinations thereof.

6 . The dosage of claim 2 , wherein said estrogen is selected from the group consisting of ethinyl estradiol, estradiol, estropipate, natural conjugated equine estrogens, conjugated synthetic estrogens, esterified estrogens, estrogen sulphamate, estrone sulfate, piperazine estrone sulfate, mestranol, estriol, estrone, estradiol valerate, dinestrol, and any combinations thereof.

7 . The dosage of claim 2 , wherein said progestagen is a natural progestagen.

8 . The dosage of claim 7 , wherein said natural progestagen is progesterone.

9 . The dosage of claim 2 , wherein the progestagen is a synthetic progestagen.

10 . The dosage of claim 9 , wherein said synthetic progestagen is selected form the group consisting of levonorgestrel, norethisterone, norethindrone, norethindrone acetate, norgestimate, norgestrel, cyproterone, desogestrel, drospirenone, ethynodol acetate, gestodene, cyperoterone, cyprotone acetate, ethynodiol diacetate, medroxyprogesterone, noreldestromin, and any combinations thereof.

11 . The dosage of claim 2 , wherein said antibiotic is present in an amount of 1 mg to 1000 mg.

12 . The dosage of claim 2 , wherein said estrogen is present in an amount of 0.005 mg to 1 mg.

13 . The dosage of claim 2 , wherein said progestagen is present in an amount of 0.01 mg to 7 mg.

14 . The dosage of claim 2 , wherein the dosage is a solid or liquid oral dosage form.

15 . The dosage of claim 2 , wherein the dosage is administered in an intravaginal form.

16 . The dosage of claim 1 ,

wherein said antibiotic is doxycycline hydrochloride and is present in an amount of 0.5 mg to 100 mg,

wherein said estrogen is ethinyl estradiol and is present in an amount of 0.005 mg to 0.06 mg, and

wherein said progestagen is drospirenone and is present in an amount of 0.1 mg to 7 mg.

17 . A method of administering the dosage of claim 2 , the method comprising the step of:

administering the dosage at a frequency of at least once per day, over a course of treatment.

18 . The method of claim 17 , further comprising the step of varying said frequency, over said course of treatment.

19 . The method of claim 19 , wherein said dosage comprises an amount of each of said antibiotic, said estrogen, and said progestagen, and the method further comprises the step of:

adjusting at least one of said amounts of said antibiotic, said estrogen, and said progestagen, over said course of treatment.

20 . The method of claim 17 , wherein said dosage is administered for menstrual suppression.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2013
From: PLAYTEX PRODUCTS, LLC; PLAYTEX PRODUCTS, INC.
To: EVEREADY BATTERY COMPANY, INC.
Reel/Frame 031143/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2010
From: DOUGHERTY, JR., EUGENE P.; KALMON, MICHAEL; GLAUG, FRANK; GORHAM, PATRICK
To: PLAYTEX PRODUCTS, LLC
Reel/Frame 023809/0761 →